Agenda

pdf_icon Downloadable Agenda

Wednesday, October 26
12:00 – 4:00 Optional Executive Education Program: Basic Financial Analysis for Life Sciences Professionals
Andrew W. Lo, MIT
Koch Institute at MIT, 500 Main Street (Building 76), Cambridge, MA 02142
Space is limited to 100 participants on a first-come-first-served basis.
5:00 – 6:00 Registration Check-In and Cocktails
Boston Marriott Cambridge
2nd Floor Salons, 2 Cambridge Center (50 Broadway), Cambridge, MA 02142
6:00 – 8:00 Welcome Dinner
Welcome Remarks: Andrew W. Lo, MIT
Opening Remarks: Greg Simon, Cancer Moonshot Task Force
Special Presentation: Parag Mallick, Stanford
Thursday, October 27
Samberg Conference Center at MIT, 7th Floor, 50 Memorial Drive (Building E52), Cambridge, MA 02142
8:00 – 8:30 Continental Breakfast and Registration Check-In
8:30 – 9:00 Welcome and Conference Background and Objectives
Andrew W. Lo, MIT
9:00 – 10:30 Session 1 – Where Are We Now and Where Do We Want to Be?
Martin Friedman, Pharmakon Advisors; Ansbert Gadicke, MPM Capital; JC Gutierrez-Ramos, Synlogic; Sean Khozin, FDA; Marty Tenenbaum, CancerCommons; Jake Xia, Harvard Management Company
10:30 – 11:00 Break
11:00 – 12:30 Session 2 – New and Emerging Business Models 1: Public-Private Partnerships
Terrance Coyne, Royalty Pharma; Jose Maria Fernandez, Spain’s Treasury Department; Neil Littman, CIRM; Chandra Ramanathan, Bayer; Theodore Schenkelberg, Human Vaccines Project; Jonathan Stamler, Harrington Discovery Institute
12:30 – 2:00 Lunch featuring Fireside Chat with Phillip A. Sharp
Moderated by Janet Wu
2:00 – 3:30 Session 3 – Innovations and Challenges in Translation and Clinical Trial Design
Chris Austin, NCATS; Scott Berry, Berry Consultants; Laura Esserman, UCSF; Jonathan Hirsch, Syapse; Monique Mansoura, MIT; Murray Sheldon, FDA
3:30 – 4:00 Break
4:00 – 5:45 Session 4 – Establishing Criteria: Analytics, Modeling, Structures and Ratings
David Agus, USC; Ronald Borod, DLA Piper; Winston Chang, Standard & Poor’s; Mark Gordon, Informa; Nick Marko, Geisinger; Tomas Philipson, University of Chicago; Roger Stein, MIT
5:45 – 6:00 Day 1 Conference Wrap-Up
6:00 Dinner featuring Fireside Chat with Bob Beall, Cystic Fibrosis Foundation
Moderated by Janet Wu
Boston Marriott Cambridge
2nd Floor Salons, 2 Cambridge Center (50 Broadway), Cambridge, MA 02142
Friday, October 28
Samberg Conference Center at MIT, 7th Floor, 50 Memorial Drive (Building E52), Cambridge, MA 02142
8:00 – 8:30 Continental Breakfast
8:30 – 10:00 Session 5 – Lessons Learned
Christiana Bardon, Burrage Capital; Anna Barker, Arizona State University; Jonathan Benjamin, Amgen; Howard Fingert, Takeda
10:00 – 10:30 Break
10:30 – 12:00 Session 6 – New and Emerging Business Models 2: Foundations, Patient Advocates, and Other Mission-Driving Organizations
Parag Mallick, Stanford; Larry Norton, Memorial Sloan Kettering Cancer Center; Julien de Salaberry, Global Cancer Research and Commercialisation Fund; Lara Sullivan, Pfizer; Laura Thrall, CureSearch
12:00 – 1:30 Lunch
Keynote Speaker: Chris Viehbacher, Gurnet Point Capital
1:30 – 3:00 Session 7 – New and Emerging Business Models 3: Private Sector Innovations
Neil Kumar, BridgeBio Capital; Andrew Lee, UBS; Amy Schulman, Polaris Partners; Mayukh Sukhatme, Roivant Sciences; Bill Symonds, Roivant Sciences
3:00 – 3:30 Break
3:30 – 5:00 Session 8 – Convergence: Innovations in Academia and Commercialization
Kevin Grimes, Stanford; Marc Goldberg, BioVentures Investors; Lita Nelsen; Jon Soderstrom, Yale
5:00 – 5:30 Day 2 Conference Wrap-Up